The Effect of Intravenous Anesthetics on Fear Learning and Memory
NCT ID: NCT00767767
Last Updated: 2019-05-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
67 participants
INTERVENTIONAL
2008-10-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To address this question, the investigators will study 114 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the "fear response", subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.
The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Memory & Conditioning Under Anesthesia
NCT04062123
Preoperative Anxiety Level, Premedications and General Anaesthetic Proceedings
NCT03603873
Propofol's Hypnotic and Memory Effects
NCT00576615
The Effect of Intravenous Versus Volatile Anesthesia on Postoperative Cognitive Dysfunction in Elderly Patients
NCT06353516
Effect of Affective Content on Drug Induced Amnesia of Episodic Memory
NCT00142493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To address this question, the investigators will study 114 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the "fear response", subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.
The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebos
Saline Infusion
Placebos
IV Saline infusion for 2 hours.
Propofol 0.45mcg/mL
Anesthetic Drug Infusion
Propofol 0.45mcg/mL
IV Propofol infusion for 2 hours.
Propofol 0.90mcg/mL
Anesthetic Drug Infusion
Propofol 0.90mcg/mL
IV Propofol infusion for 2 hours.
Thiopental 1.5mcg/mL
Anesthetic Drug Infusion
Thiopental 1.5mcg/mL
IV Thiopental 1.5mcg/mL infusion for 2 hours
Thiopental 3mcg/mL
Anesthetic Drug Infusion
Thiopental 3mcg/mL
IV Thiopental 3mcg/mL infusion for 2 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebos
IV Saline infusion for 2 hours.
Propofol 0.45mcg/mL
IV Propofol infusion for 2 hours.
Propofol 0.90mcg/mL
IV Propofol infusion for 2 hours.
Thiopental 1.5mcg/mL
IV Thiopental 1.5mcg/mL infusion for 2 hours
Thiopental 3mcg/mL
IV Thiopental 3mcg/mL infusion for 2 hours
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minimum of high school education
* fluent in English
* normal vocabulary
Exclusion Criteria
* deficit in vision or hearing that would impede the study
* allergies to any of the study drugs, to soybeans, or to eggs
* a history of head trauma
* a family history of major psychiatric illness
* body mass index \> 30 kg/m2
* a recent history of recreational drug use
* prior exposure to the study materials
* pregnancy
* a personal or family history of any porphyria
* failure to exhibit a skin conductance response to deep inspiration
* the ability to read Chinese characters
* assessment by the investigators that the subject may be unable to cooperate or comply with the study requirements.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of General Medical Sciences (NIGMS)
NIH
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kane Pryor, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weill Cornell Medical College/New York Presbyterian Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0710009434
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.